Replies to post #142501 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

With capitulation on the amyloid theory, does BP start looking at who else is out there with a different approach?

Alz is still the holy grail of blockbuster drugs. It is well documented that an effective drug is worth $20 billion in mkt cap. (Not to mention double or triple that if the drug has effectiveness against other CNS diseases).

So how long before BP and Wall Street start to give us a serious look?

Methinks it starts now.